New antimalarial drug requires higher doses to cure infection, suggests study


A new antimalarial drug is being introduced at a dose that is too low to be effective for all patients who need it, according to a report published today in eLife.

Use of hearing aids and cochlear implants associated with a decreased risk of developing dementia

Previous article

How dementia caregivers can cope with the holidays

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations